X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2023/12/21/2800335/0/en/Topline-Results-from-MYLOX-1-Trial-Demonstrate-Reduction-in-Fibrosis-of-the-Bone-Marrow-in-Patients-with-Myelofibrosis.html
https://www.fiercebiotech.com/biotech/galecto-posts-myelofibrosis-data-search-savior-continues-investors-shrug
https://www.globenewswire.com//news-release/2023/10/23/2764667/0/en/Galecto-Presents-Updated-Clinical-Data-at-ESMO-Congress-2023-and-Provides-Update-on-Phase-1b-2a-GALLANT-1-Trial.html
https://www.fiercebiotech.com/biotech/galecto-lays-70-hunts-strategic-alternatives-wake-fibrosis-drug-fail
https://www.globenewswire.com//news-release/2023/09/26/2749923/0/en/Galecto-Announces-Plans-to-Explore-Strategic-Alternatives.html
https://www.globenewswire.com//news-release/2023/08/31/2735493/0/en/Galecto-to-Present-at-Investor-Conferences-in-September.html
https://www.biospace.com/article/galecto-drops-idiopathic-pulmonary-fibrosis-hopeful-after-phase-ii-flop/
https://www.globenewswire.com/news-release/2023/07/31/2715294/0/en/Galecto-Reports-Second-Quarter-Operating-and-Financial-Results.html
https://www.globenewswire.com/news-release/2023/06/20/2691113/0/en/Galecto-Set-to-Join-Russell-Microcap-Index.html
https://www.globenewswire.com/news-release/2023/05/30/2678273/0/en/Galecto-to-Present-at-the-Upcoming-Jefferies-Healthcare-Conference.html
Market Place
Share 
